Gefitrust Tablet is prescribed for cancer treatment It targets the epidermal growth factor receptor EGFR found in both normal and cancer cells disrupting signals necessary for cancer cell growth Gefitinib is a cancer medication that inhibits cancer cell growth and is used for certain types of cancers It interrupts communication pathways crucial for cancer cell growth and survival by hindering specific proteins related to the EGFR receptor Taking this medicine with or without food is acceptable but maintaining a consistent daily time is recommended Common side effects include diarrhea dry skin loss of appetite nausea rash stomatitis vomiting weakness and weight loss It has been linked to an increased risk of interstitial lung disease and patients should be monitored for symptoms such as cough difficulty breathing and fever Consult your doctor for guidance on managing missed doses effectively